HWKN · NASDAQ · Chemicals - Specialty

Hawkins (HWKN)

Blends chemicals and ingredients for water treatment, food, health, and industrial customers.

$126.26
vs last close+0.87 (+0.69%)
Loading prices…

Hawkins, Inc.HWKN
Materials

Formulates, manufactures, blends, and distributes chemicals and specialty ingredients for water treatment, food and health sciences, and industrial markets. Water treatment is the largest segment, combining chemicals with equipment, engineered systems, rentals, and technician-supported delivery across a growing U.S. branch network.

Formulates, manufactures, blends, and distributes chemicals and specialty ingredients through Water Treatment, Food and Health Sciences, and Industrial Solutions. Water Treatment combines treatment chemicals with filtration media, equipment, engineered systems, rentals, and technician-supported delivery for municipal, industrial, pool, and agricultural water customers, mainly across the eastern two-thirds of the United States.

Food and Health Sciences supplies nutrition, food, pharmaceutical, and agricultural manufacturers with ingredients, formulation, processing, and blending. Industrial Solutions handles acids, alkalis, custom blends, and repackaged bulk chemicals through plants and terminals. Shared raw materials and facilities support purchasing efficiency, while acquisitions broaden the water-treatment footprint. Operations depend on chemical availability, logistics, integration, and environmental, safety, transport, storage, and product regulation.

Company facts

CEOPatrick H. Hawkins
ListedMar 18, 1980
ExchangeNASDAQ
HeadquartersRoseville, MN
CountryUnited States
Employees1,200
CIK0000046250
ISINUS4202611095

Market cap$2.62B
EPS (ttm)$3.86
P/E (ttm)32.48
ROE15.3%
P/B4.77
P/S2.37
Dividend yieldDiv yield0.61%
Beta0.74vs XLB 0.95

Price target$142.00+13.2%Average of 2 analysts
ConsensusBuy1 of 2 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Jul 31, 2026BarclaysReiterate
Rating: Target: $170
Rating: Equal WeightTarget: $142
Jun 30, 2026BarclaysTarget
Target:
Target: $170
Apr 14, 2025BWS FinancialUpgrade
Rating: Neutral
Rating: Buy
Oct 16, 2024BWS FinancialDowngrade
Rating: Buy
Rating: Neutral

Next report
Nov 4, 26
estimated · in 43 days
EPS estimate
$1.22
Revenue estimate
$302.7M
Fiscal quarter
Q2 FY27

EPSReportedEstimate

Jan '25May '25Jul '25Oct '25Jan '26May '26Jul '26Nov '26
Reported$0.72$0.78$1.40$1.08$0.72$0.74$1.35Pending
Estimate$0.77$0.74$1.33$1.24$0.75$0.76$1.39$1.22
Surprise−6.5%+5.4%+5.3%−12.9%−4.0%−2.6%−2.9%

RevenueReportedEstimate

Jan '25May '25Jul '25Oct '25Jan '26May '26Jul '26Nov '26
Reported$226.2M$245.3M$293.3M$280.4M$244.1M$265.9M$315.7MPending
Estimate$228.0M$269.2M$277.4M$259.9M$252.5M$255.3M$313.4M$302.7M
Surprise−0.8%−8.9%+5.7%+7.9%−3.3%+4.2%+0.7%
Estimate$1.22
ReportedDue Nov 4, 2026
Estimate$302.7M
ReportedDue Nov 4, 2026
View details

Debt to equity47.50%
Current ratio227.00%

ProfitabilityRevenueNet incomeNet margin

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue$247.0M$226.2M$245.3M$293.3M$280.4M$244.1M$265.9M$315.7M
Net income$24.1M$15.0M$16.3M$29.2M$22.6M$14.3M$15.5M$28.3M
Net margin9.8%6.6%6.7%9.9%8.1%5.9%5.8%9.0%

GrowthOperating income

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Operating income$33.7M$21.4M$24.9M$39.8M$34.5M$18.8M$22.1M$38.7M
YoY growth+2.3%+15.9%+24.1%−0.1%+2.2%−12.0%−11.5%−2.7%

Balance sheet, Jun 28, 2026Cash & short-term investments $8.0M · Total debt $260.7M · Total assets $1.01B · Shareholders' equity $548.2M

Revenue
$315.7M
Operating income
$38.7M
Net income
$28.3M
View details

Dividend yield
0.61%
Next ex-date
Nov 14, 26
estimated · in 53 days
Annual dividend
$0.77
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26
Dividend$0.18$0.18$0.18$0.19$0.19$0.19$0.19$0.20
Annual yield0.55%0.63%0.54%0.43%0.58%0.51%0.49%0.59%
Ex-dateNov 15Feb 14May 30Aug 15Nov 14Feb 13May 29Aug 14
Payment dateNov 29Feb 28Jun 13Aug 29Nov 28Feb 27Jun 12Aug 28
View details

Institutions79.11%16.51M shares
338 holders · as of Jun 30, 2026
Insiders4.02%840.2K shares
16 holders · as of Aug 31, 2026
Other16.87%3.52M shares
remainder

20.88M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
15.14%3.16Mas of Jun 30, 2026
Kayne Anderson Rudnick Investment Management LLCInstitution
6.84%1.43Mas of Jun 30, 2026
State Street CorpInstitution
5.09%1.06Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.09%854,478as of Jun 30, 2026
Geode Capital Management, LLCInstitution
2.62%547,510as of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 27, 2026Jeffrey P. Oldenkampofficer: EXECUTIVE VP AND CFO+1,290$119.00
Aug 25, 2026Douglas A. Langeofficer: VP - WATER TREATMENT GROUP+910$118.75
Feb 4, 2026James A. Faulconbridgedirector+1,500$129.29
Feb 5, 2026James A. Faulconbridgedirector+1,500$129.95
Nov 3, 2025Drew M. Grahekofficer: VICE PRESIDENT OF OPERATIONS+1,587$126.34
View details

  • Ecolab

    Broad water, hygiene, and food-safety service overlap

  • Xylem

    Water equipment, filtration, and service systems

  • Olin

    Chlor-alkali producer against bulk chemical supply

  • Ingredion

    Food, nutrition, and industrial ingredient solutions

  • Balchem

    Nutrition, pharma, and specialty performance ingredients

  • Sensient Technologies

    Colors, flavors, and pharma ingredient systems

Compare

CompanyPriceChange
Hawkins$126.26+0.69%$2.62B32.530.12.4+7.6%
Ecolab$273.68+1.37%$75.98B36.231.74.5+9.7%
Xylem$107.15−0.08%$25.04B25.518.22.7+1.5%
Olin$16.96+2.54%$1.89B52.30.3−0.9%
Ingredion$97.83+0.82%$6.12B10.68.80.8+0.9%
Balchem$169.14+1.08%$5.38B32.930.45.0+11.2%
Sensient Technologies$132.09+1.88%$5.52B34.929.83.2+11.6%
Median32.930.13.0+5.6%